The IIN is partnering with Nanyang Technological University (NTU), Singapore, to establish a $70 million institute to support research into nanomedicine.
The NTU-NU Nanomedicine Institute will support scientists from both institutions working collaboratively on research projects in the areas of disease diagnostics, timed-release therapeutics, and targeted drug delivery methods, which would greatly increase the efficacy of existing drugs and therapies, while enabling earlier and more rapid detection of diseases. Researchers will also design new methodologies, such as gene silencing and theranostics, to treat diseases, with emphasis on cardiovascular, ocular, skin, and endocrinological disease.
The Executive Committee for this new Institute is currently reviewing proposals for funding and information about the funded research efforts will be available on this site as soon as awards are made.
Sign up for our newsletter to receive information on events, news, and articles.